Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times
daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of
endogenous anterior uveitis.